Retrieved from Mutuyemungu, E., Singh, M., Liu, S., et al
In the semaglutide cohort, the initial injection dosage was 0.25 mg/week and gradually increased to 0.5, 1.0, 1.7, and 2.4 mg at weeks four, eight, 12, and 16, respectively
NHS Blood and Transplant (NHSBT) and other UK donation services (Scottish National Blood Transfusion Service, Welsh Blood Service, and Northern Ireland Blood Transfusion Service) maintain comprehensive medication guidelines to protect both donors and recipients
In absolute terms, tirzepatide users lost an average of 22.8kg (about 50 pounds) compared to 15.0kg (about 33 pounds) with semaglutide
While semaglutide provides pharmacological support for weight loss, lifestyle factors remain critical determinants of success